- Home
- AQST vs FDBC Comparison
AQST vs FDBC Comparison
Compare AQST & FDBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AQST
- FDBC
- Stock Information
- Founded
- AQST 2004
- FDBC 1902
- Country
- AQST United States
- FDBC United States
- Employees
- AQST 135
- FDBC N/A
- Industry
- AQST Biotechnology: Pharmaceutical Preparations
- FDBC Major Banks
- Sector
- AQST Health Care
- FDBC Finance
- Exchange
- AQST Nasdaq
- FDBC Nasdaq
- Market Cap
- AQST 274.4M
- FDBC 253.4M
- IPO Year
- AQST 2018
- FDBC N/A
- Fundamental
- Price
- AQST $3.01
- FDBC $43.45
- Analyst Decision
- AQST Strong Buy
- FDBC
- Analyst Count
- AQST 8
- FDBC 0
- Target Price
- AQST $10.38
- FDBC N/A
- AVG Volume (30 Days)
- AQST 2.0M
- FDBC 6.1K
- Earning Date
- AQST 03-05-2025
- FDBC 01-29-2025
- Dividend Yield
- AQST N/A
- FDBC 3.68%
- EPS Growth
- AQST N/A
- FDBC 12.85
- EPS
- AQST N/A
- FDBC 3.60
- Revenue
- AQST $58,900,000.00
- FDBC $79,413,000.00
- Revenue This Year
- AQST $18.44
- FDBC N/A
- Revenue Next Year
- AQST N/A
- FDBC N/A
- P/E Ratio
- AQST N/A
- FDBC $12.07
- Revenue Growth
- AQST 22.56
- FDBC 9.77
- 52 Week Low
- AQST $2.24
- FDBC $41.00
- 52 Week High
- AQST $6.23
- FDBC $61.21
- Technical
- Relative Strength Index (RSI)
- AQST 43.29
- FDBC 42.14
- Support Level
- AQST $2.95
- FDBC $43.21
- Resistance Level
- AQST $3.21
- FDBC $45.00
- Average True Range (ATR)
- AQST 0.20
- FDBC 1.38
- MACD
- AQST 0.02
- FDBC -0.05
- Stochastic Oscillator
- AQST 18.42
- FDBC 12.97
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Sympazan Oral Film, Suboxone Sublingual Film, Exservan Oral Film, and Zuplenz. The product pipeline includes Libervant Buccal Film, AQST-108, and AQST-305. The majority of its revenue comes from the United States.
About FDBC Fidelity D & D Bancorp Inc.
Fidelity D & D Bancorp Inc is a bank holding company. Through its wholly-owned state-chartered commercial bank subsidiary, The Fidelity Deposit and Discount Bank (the Bank), it offers a full range of traditional banking services. The Bank has a personal and corporate trust department and also provides alternative financial and insurance products with asset management services. Its primary market areas are Lackawanna, Luzerne and Northampton Counties, Pennsylvania. The company's primary deposit products are demand deposits and interest-bearing time, money market and savings accounts. It offers a full array of loan products to meet the needs of retail and commercial customers.